Skip to content
Review Open access

Systematic Review: Inclusion of Patients With Difficult‐to‐Treat Inflammatory Bowel Disease in Randomized Controlled Trials of Advanced Therapies

Oct 2026 · Alimentary Pharmacology and Therapeutics · Vol 64, pp. 1379 - 1389 · 0 citations · 60 references
Medicine

Abstract

Criteria to define difficult‐to‐treat (DTT) inflammatory bowel disease (IBD) have recently been proposed, yet the inclusion and participation of patients with DTT‐IBD in randomized controlled trials (RCTs) are heterogeneous and poorly defined.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.